nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—female reproductive system—urinary bladder cancer	0.0292	0.2	CbGeAlD
Pentosan Polysulfate—FGF2—prostate gland—urinary bladder cancer	0.019	0.13	CbGeAlD
Pentosan Polysulfate—FGF1—prostate gland—urinary bladder cancer	0.0141	0.0967	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—urinary bladder cancer	0.0135	0.092	CbGeAlD
Pentosan Polysulfate—FGF2—urethra—urinary bladder cancer	0.0127	0.087	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—urinary bladder cancer	0.0104	0.071	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—urinary bladder cancer	0.01	0.0684	CbGeAlD
Pentosan Polysulfate—FGF1—renal system—urinary bladder cancer	0.00964	0.0659	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—urinary bladder cancer	0.00939	0.0642	CbGeAlD
Pentosan Polysulfate—FGF1—female reproductive system—urinary bladder cancer	0.00772	0.0528	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—urinary bladder cancer	0.00607	0.0415	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—urinary bladder cancer	0.00452	0.0309	CbGeAlD
Pentosan Polysulfate—Oedema—Gemcitabine—urinary bladder cancer	0.000661	0.00172	CcSEcCtD
Pentosan Polysulfate—Infection—Gemcitabine—urinary bladder cancer	0.000657	0.00171	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—urinary bladder cancer	0.000652	0.0017	CcSEcCtD
Pentosan Polysulfate—Oedema—Fluorouracil—urinary bladder cancer	0.00065	0.00169	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000648	0.00169	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000647	0.00169	CcSEcCtD
Pentosan Polysulfate—Infection—Fluorouracil—urinary bladder cancer	0.000646	0.00168	CcSEcCtD
Pentosan Polysulfate—Myalgia—Cisplatin—urinary bladder cancer	0.000643	0.00167	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000643	0.00167	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000642	0.00167	CcSEcCtD
Pentosan Polysulfate—Anaemia—Etoposide—urinary bladder cancer	0.000639	0.00166	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000639	0.00166	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000636	0.00166	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000635	0.00165	CcSEcCtD
Pentosan Polysulfate—Discomfort—Cisplatin—urinary bladder cancer	0.000635	0.00165	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—urinary bladder cancer	0.000634	0.00165	CcSEcCtD
Pentosan Polysulfate—Anorexia—Gemcitabine—urinary bladder cancer	0.00063	0.00164	CcSEcCtD
Pentosan Polysulfate—Urticaria—Thiotepa—urinary bladder cancer	0.000624	0.00163	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—urinary bladder cancer	0.000624	0.00162	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Thiotepa—urinary bladder cancer	0.000621	0.00162	CcSEcCtD
Pentosan Polysulfate—Anorexia—Fluorouracil—urinary bladder cancer	0.000619	0.00161	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—urinary bladder cancer	0.000619	0.00161	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—urinary bladder cancer	0.000616	0.0016	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—urinary bladder cancer	0.000612	0.00159	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—urinary bladder cancer	0.00061	0.00159	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000603	0.00157	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000602	0.00157	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—urinary bladder cancer	0.000599	0.00156	CcSEcCtD
Pentosan Polysulfate—Insomnia—Gemcitabine—urinary bladder cancer	0.000598	0.00156	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000596	0.00155	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000594	0.00155	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000594	0.00155	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000592	0.00154	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000589	0.00153	CcSEcCtD
Pentosan Polysulfate—Insomnia—Fluorouracil—urinary bladder cancer	0.000588	0.00153	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—urinary bladder cancer	0.000587	0.00153	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—urinary bladder cancer	0.000586	0.00153	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000584	0.00152	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—urinary bladder cancer	0.000582	0.00151	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000579	0.00151	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000579	0.00151	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000575	0.0015	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000572	0.00149	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00057	0.00148	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—urinary bladder cancer	0.00057	0.00148	CcSEcCtD
Pentosan Polysulfate—Constipation—Gemcitabine—urinary bladder cancer	0.000565	0.00147	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000565	0.00147	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—urinary bladder cancer	0.000564	0.00147	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000561	0.00146	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—urinary bladder cancer	0.000561	0.00146	CcSEcCtD
Pentosan Polysulfate—Pruritus—Thiotepa—urinary bladder cancer	0.000556	0.00145	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—urinary bladder cancer	0.000554	0.00144	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—urinary bladder cancer	0.000553	0.00144	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000553	0.00144	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.00055	0.00143	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—urinary bladder cancer	0.000549	0.00143	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000546	0.00142	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000545	0.00142	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000543	0.00141	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—urinary bladder cancer	0.000542	0.00141	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—urinary bladder cancer	0.000538	0.0014	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Thiotepa—urinary bladder cancer	0.000538	0.0014	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—urinary bladder cancer	0.000536	0.00139	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000536	0.00139	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—urinary bladder cancer	0.000529	0.00138	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—urinary bladder cancer	0.000527	0.00137	CcSEcCtD
Pentosan Polysulfate—Dizziness—Thiotepa—urinary bladder cancer	0.00052	0.00135	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Methotrexate—urinary bladder cancer	0.000517	0.00135	CcSEcCtD
Pentosan Polysulfate—Urticaria—Fluorouracil—urinary bladder cancer	0.000516	0.00134	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000515	0.00134	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—urinary bladder cancer	0.000514	0.00134	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—urinary bladder cancer	0.000508	0.00132	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000508	0.00132	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000508	0.00132	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—urinary bladder cancer	0.000507	0.00132	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—urinary bladder cancer	0.000506	0.00132	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—urinary bladder cancer	0.000505	0.00132	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—urinary bladder cancer	0.000503	0.00131	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—urinary bladder cancer	0.000503	0.00131	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000501	0.00131	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Methotrexate—urinary bladder cancer	0.0005	0.0013	CcSEcCtD
Pentosan Polysulfate—Vomiting—Thiotepa—urinary bladder cancer	0.0005	0.0013	CcSEcCtD
Pentosan Polysulfate—Rash—Thiotepa—urinary bladder cancer	0.000495	0.00129	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Thiotepa—urinary bladder cancer	0.000495	0.00129	CcSEcCtD
Pentosan Polysulfate—Headache—Thiotepa—urinary bladder cancer	0.000492	0.00128	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—urinary bladder cancer	0.000491	0.00128	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—urinary bladder cancer	0.000484	0.00126	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—urinary bladder cancer	0.000484	0.00126	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—urinary bladder cancer	0.000483	0.00126	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000482	0.00126	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000479	0.00125	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—urinary bladder cancer	0.000476	0.00124	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000476	0.00124	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—urinary bladder cancer	0.000473	0.00123	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—urinary bladder cancer	0.000472	0.00123	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00047	0.00122	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—urinary bladder cancer	0.000469	0.00122	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—urinary bladder cancer	0.000468	0.00122	CcSEcCtD
Pentosan Polysulfate—Pruritus—Gemcitabine—urinary bladder cancer	0.000468	0.00122	CcSEcCtD
Pentosan Polysulfate—Nausea—Thiotepa—urinary bladder cancer	0.000467	0.00122	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—urinary bladder cancer	0.000466	0.00121	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—urinary bladder cancer	0.000465	0.00121	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000465	0.00121	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000462	0.0012	CcSEcCtD
Pentosan Polysulfate—Pruritus—Fluorouracil—urinary bladder cancer	0.00046	0.0012	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000454	0.00118	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000452	0.00118	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—urinary bladder cancer	0.000448	0.00117	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—urinary bladder cancer	0.000447	0.00116	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—urinary bladder cancer	0.000447	0.00116	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—urinary bladder cancer	0.000446	0.00116	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—urinary bladder cancer	0.000446	0.00116	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000446	0.00116	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000445	0.00116	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Methotrexate—urinary bladder cancer	0.000444	0.00116	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—urinary bladder cancer	0.000442	0.00115	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—urinary bladder cancer	0.00044	0.00115	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—urinary bladder cancer	0.000438	0.00114	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—urinary bladder cancer	0.000433	0.00113	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—urinary bladder cancer	0.000431	0.00112	CcSEcCtD
Pentosan Polysulfate—Dizziness—Fluorouracil—urinary bladder cancer	0.00043	0.00112	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000422	0.0011	CcSEcCtD
Pentosan Polysulfate—Alopecia—Methotrexate—urinary bladder cancer	0.000421	0.00109	CcSEcCtD
Pentosan Polysulfate—Vomiting—Gemcitabine—urinary bladder cancer	0.00042	0.00109	CcSEcCtD
Pentosan Polysulfate—Rash—Gemcitabine—urinary bladder cancer	0.000417	0.00109	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000416	0.00108	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000416	0.00108	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—urinary bladder cancer	0.000415	0.00108	CcSEcCtD
Pentosan Polysulfate—Headache—Gemcitabine—urinary bladder cancer	0.000414	0.00108	CcSEcCtD
Pentosan Polysulfate—Vomiting—Fluorouracil—urinary bladder cancer	0.000413	0.00108	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—urinary bladder cancer	0.000413	0.00108	CcSEcCtD
Pentosan Polysulfate—Rash—Fluorouracil—urinary bladder cancer	0.00041	0.00107	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000409	0.00107	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000409	0.00106	CcSEcCtD
Pentosan Polysulfate—Headache—Fluorouracil—urinary bladder cancer	0.000407	0.00106	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—urinary bladder cancer	0.000399	0.00104	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—urinary bladder cancer	0.000394	0.00102	CcSEcCtD
Pentosan Polysulfate—Nausea—Gemcitabine—urinary bladder cancer	0.000393	0.00102	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—urinary bladder cancer	0.000392	0.00102	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—urinary bladder cancer	0.000388	0.00101	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—urinary bladder cancer	0.000388	0.00101	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—urinary bladder cancer	0.000386	0.00101	CcSEcCtD
Pentosan Polysulfate—Nausea—Fluorouracil—urinary bladder cancer	0.000386	0.00101	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000384	0.001	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—urinary bladder cancer	0.000384	0.001	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—urinary bladder cancer	0.000383	0.000997	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—urinary bladder cancer	0.000382	0.000995	CcSEcCtD
Pentosan Polysulfate—Malaise—Methotrexate—urinary bladder cancer	0.000374	0.000973	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—urinary bladder cancer	0.000373	0.000972	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Methotrexate—urinary bladder cancer	0.000371	0.000965	CcSEcCtD
Pentosan Polysulfate—Nausea—Cisplatin—urinary bladder cancer	0.000366	0.000953	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—urinary bladder cancer	0.000364	0.000948	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00036	0.000937	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—urinary bladder cancer	0.000359	0.000934	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—urinary bladder cancer	0.000358	0.000933	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—urinary bladder cancer	0.000356	0.000928	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—urinary bladder cancer	0.000356	0.000927	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—urinary bladder cancer	0.000356	0.000926	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—urinary bladder cancer	0.000354	0.000921	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—urinary bladder cancer	0.000353	0.00092	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—urinary bladder cancer	0.000353	0.000918	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Methotrexate—urinary bladder cancer	0.000353	0.000918	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—urinary bladder cancer	0.00035	0.00091	CcSEcCtD
Pentosan Polysulfate—Discomfort—Methotrexate—urinary bladder cancer	0.000348	0.000907	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—urinary bladder cancer	0.000347	0.000904	CcSEcCtD
Pentosan Polysulfate—Infection—Methotrexate—urinary bladder cancer	0.000336	0.000875	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—urinary bladder cancer	0.000335	0.000873	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000333	0.000867	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—urinary bladder cancer	0.000332	0.000863	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000331	0.000862	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—urinary bladder cancer	0.00033	0.000859	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—urinary bladder cancer	0.00033	0.000859	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—urinary bladder cancer	0.00033	0.000858	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000327	0.000851	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—urinary bladder cancer	0.000326	0.000849	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—urinary bladder cancer	0.000323	0.000842	CcSEcCtD
Pentosan Polysulfate—Anorexia—Methotrexate—urinary bladder cancer	0.000322	0.000839	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—urinary bladder cancer	0.000321	0.000836	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—urinary bladder cancer	0.000316	0.000824	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—urinary bladder cancer	0.000314	0.000818	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00031	0.000807	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000308	0.000802	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000306	0.000796	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—urinary bladder cancer	0.000306	0.000796	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—urinary bladder cancer	0.000305	0.000795	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—urinary bladder cancer	0.000305	0.000795	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000304	0.00079	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—urinary bladder cancer	0.000302	0.000786	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—urinary bladder cancer	0.000302	0.000785	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000301	0.000785	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—urinary bladder cancer	0.000298	0.000775	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000294	0.000765	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—urinary bladder cancer	0.000293	0.000762	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—urinary bladder cancer	0.000291	0.000757	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000288	0.000751	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000287	0.000746	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—urinary bladder cancer	0.000286	0.000745	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000284	0.00074	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000283	0.000737	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000282	0.000734	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—urinary bladder cancer	0.000279	0.000727	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000279	0.000725	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—urinary bladder cancer	0.000279	0.000725	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000276	0.00072	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—urinary bladder cancer	0.000275	0.000716	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—urinary bladder cancer	0.000271	0.000704	CcSEcCtD
Pentosan Polysulfate—Urticaria—Methotrexate—urinary bladder cancer	0.000269	0.000699	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000267	0.000696	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000267	0.000694	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—urinary bladder cancer	0.000265	0.000689	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000263	0.000684	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000261	0.00068	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000261	0.000679	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000259	0.000674	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000258	0.000671	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000254	0.000663	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—urinary bladder cancer	0.000251	0.000654	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—urinary bladder cancer	0.00025	0.000652	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—urinary bladder cancer	0.00025	0.000651	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000249	0.000649	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000241	0.000628	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000239	0.000623	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—urinary bladder cancer	0.000239	0.000623	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000233	0.000607	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—urinary bladder cancer	0.000233	0.000606	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000231	0.000603	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000231	0.000602	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—urinary bladder cancer	0.000224	0.000583	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—urinary bladder cancer	0.000224	0.000582	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000216	0.000564	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000216	0.000562	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—urinary bladder cancer	0.000215	0.00056	CcSEcCtD
Pentosan Polysulfate—Rash—Methotrexate—urinary bladder cancer	0.000213	0.000555	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Methotrexate—urinary bladder cancer	0.000213	0.000555	CcSEcCtD
Pentosan Polysulfate—Headache—Methotrexate—urinary bladder cancer	0.000212	0.000551	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—urinary bladder cancer	0.000209	0.000545	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—urinary bladder cancer	0.000207	0.000539	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—urinary bladder cancer	0.000201	0.000524	CcSEcCtD
Pentosan Polysulfate—Nausea—Methotrexate—urinary bladder cancer	0.000201	0.000523	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.0002	0.000522	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—urinary bladder cancer	0.000199	0.000519	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—urinary bladder cancer	0.000199	0.000519	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—urinary bladder cancer	0.000198	0.000516	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—urinary bladder cancer	0.000194	0.000504	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—urinary bladder cancer	0.000188	0.000489	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—urinary bladder cancer	0.000186	0.000485	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—urinary bladder cancer	0.000185	0.000481	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000184	0.00048	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—urinary bladder cancer	0.000183	0.000478	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—ERCC2—urinary bladder cancer	0.000176	0.000375	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ENO2—urinary bladder cancer	0.000176	0.000374	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—urinary bladder cancer	0.000175	0.000372	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—CDKN1A—urinary bladder cancer	0.000174	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PTEN—urinary bladder cancer	0.000174	0.000371	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Doxorubicin—urinary bladder cancer	0.000174	0.000453	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—urinary bladder cancer	0.000174	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—FGFR3—urinary bladder cancer	0.000172	0.000366	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CDKN1A—urinary bladder cancer	0.000172	0.000366	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PTEN—urinary bladder cancer	0.000171	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GLI1—urinary bladder cancer	0.00017	0.000362	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—HRAS—urinary bladder cancer	0.000169	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—HRAS—urinary bladder cancer	0.000167	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—urinary bladder cancer	0.000167	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—HRAS—urinary bladder cancer	0.000167	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RBX1—urinary bladder cancer	0.000167	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MTHFR—urinary bladder cancer	0.000166	0.000353	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TERT—urinary bladder cancer	0.000165	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—HRAS—urinary bladder cancer	0.000165	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.000165	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PTEN—urinary bladder cancer	0.000165	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—FGFR3—urinary bladder cancer	0.000164	0.00035	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.000164	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PPARG—urinary bladder cancer	0.000164	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—urinary bladder cancer	0.000164	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EP300—urinary bladder cancer	0.000164	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—JAG1—urinary bladder cancer	0.000163	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—FGFR3—urinary bladder cancer	0.000163	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—urinary bladder cancer	0.000163	0.000347	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	0.000162	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—SRC—urinary bladder cancer	0.000161	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—SRC—urinary bladder cancer	0.000159	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CREBBP—urinary bladder cancer	0.000157	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—FGFR3—urinary bladder cancer	0.000157	0.000334	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—urinary bladder cancer	0.000155	0.00033	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—urinary bladder cancer	0.000154	0.000329	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—SRC—urinary bladder cancer	0.000153	0.000325	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CREBBP—urinary bladder cancer	0.000152	0.000325	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—FGFR3—urinary bladder cancer	0.000152	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNA2—urinary bladder cancer	0.000152	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—JAG1—urinary bladder cancer	0.000149	0.000317	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—urinary bladder cancer	0.000148	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—urinary bladder cancer	0.000147	0.000312	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—S100B—urinary bladder cancer	0.000146	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDH1—urinary bladder cancer	0.000145	0.000309	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—S100B—urinary bladder cancer	0.000143	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—RHOA—urinary bladder cancer	0.000142	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—urinary bladder cancer	0.000141	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CREBBP—urinary bladder cancer	0.00014	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—urinary bladder cancer	0.000139	0.000297	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CREBBP—urinary bladder cancer	0.000139	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDH1—urinary bladder cancer	0.000139	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNA2—urinary bladder cancer	0.000138	0.000294	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—urinary bladder cancer	0.000134	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—urinary bladder cancer	0.000134	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDH1—urinary bladder cancer	0.000132	0.000282	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ERBB2—urinary bladder cancer	0.000132	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—urinary bladder cancer	0.000132	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NCOR1—urinary bladder cancer	0.000131	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—S100B—urinary bladder cancer	0.000131	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CREBBP—urinary bladder cancer	0.000129	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RBX1—urinary bladder cancer	0.000128	0.000272	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB2—urinary bladder cancer	0.000128	0.000272	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—urinary bladder cancer	0.000126	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—urinary bladder cancer	0.000125	0.000265	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB2—urinary bladder cancer	0.000123	0.000261	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSC1—urinary bladder cancer	0.00012	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NCOR1—urinary bladder cancer	0.000119	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB2—urinary bladder cancer	0.000117	0.000249	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—RHOA—urinary bladder cancer	0.000117	0.000249	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RBX1—urinary bladder cancer	0.000117	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB2—urinary bladder cancer	0.000116	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TERT—urinary bladder cancer	0.000116	0.000246	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JAG1—urinary bladder cancer	0.000114	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—urinary bladder cancer	0.000114	0.000242	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—urinary bladder cancer	0.000113	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERCC2—urinary bladder cancer	0.000112	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—urinary bladder cancer	0.000112	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB2—urinary bladder cancer	0.000112	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSC1—urinary bladder cancer	0.00011	0.000234	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CDKN1A—urinary bladder cancer	0.000109	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PTEN—urinary bladder cancer	0.000109	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NCOR1—urinary bladder cancer	0.000109	0.000231	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB2—urinary bladder cancer	0.000108	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—urinary bladder cancer	0.000107	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EP300—urinary bladder cancer	0.000107	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGFR3—urinary bladder cancer	0.000106	0.000226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL2—urinary bladder cancer	0.000106	0.000226	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—urinary bladder cancer	0.000106	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTHFR—urinary bladder cancer	0.000105	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TERT—urinary bladder cancer	0.000105	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CDKN1A—urinary bladder cancer	0.000105	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PTEN—urinary bladder cancer	0.000105	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JAG1—urinary bladder cancer	0.000104	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGFR3—urinary bladder cancer	0.000104	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—SRC—urinary bladder cancer	0.000104	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EP300—urinary bladder cancer	0.000104	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ESR1—urinary bladder cancer	0.000103	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERCC2—urinary bladder cancer	0.000102	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—SRC—urinary bladder cancer	0.000101	0.000215	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CDKN1A—urinary bladder cancer	0.0001	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—urinary bladder cancer	9.99e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CDKN1A—urinary bladder cancer	9.95e-05	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—urinary bladder cancer	9.93e-05	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SRC—urinary bladder cancer	9.69e-05	0.000206	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGFR3—urinary bladder cancer	9.63e-05	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—urinary bladder cancer	9.59e-05	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—urinary bladder cancer	9.57e-05	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1A—urinary bladder cancer	9.55e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—urinary bladder cancer	9.53e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EP300—urinary bladder cancer	9.52e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FGFR3—urinary bladder cancer	9.51e-05	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EP300—urinary bladder cancer	9.47e-05	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—S100B—urinary bladder cancer	9.27e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SRC—urinary bladder cancer	9.26e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1A—urinary bladder cancer	9.24e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—urinary bladder cancer	9.22e-05	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—SRC—urinary bladder cancer	9.2e-05	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—urinary bladder cancer	9.13e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CREBBP—urinary bladder cancer	9.04e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1—urinary bladder cancer	8.93e-05	0.00019	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CREBBP—urinary bladder cancer	8.88e-05	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—urinary bladder cancer	8.85e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SRC—urinary bladder cancer	8.84e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—urinary bladder cancer	8.81e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EP300—urinary bladder cancer	8.79e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FGFR3—urinary bladder cancer	8.78e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—urinary bladder cancer	8.7e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—urinary bladder cancer	8.63e-05	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SRC—urinary bladder cancer	8.55e-05	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—urinary bladder cancer	8.5e-05	0.000181	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—S100B—urinary bladder cancer	8.45e-05	0.00018	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—urinary bladder cancer	8.36e-05	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NCOR1—urinary bladder cancer	8.34e-05	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CREBBP—urinary bladder cancer	8.2e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RHOA—urinary bladder cancer	8.18e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—urinary bladder cancer	8.12e-05	0.000173	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREBBP—urinary bladder cancer	8.09e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—urinary bladder cancer	8.07e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—urinary bladder cancer	8.03e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—urinary bladder cancer	8.03e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—urinary bladder cancer	7.75e-05	0.000165	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—urinary bladder cancer	7.67e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—urinary bladder cancer	7.66e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—urinary bladder cancer	7.62e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NCOR1—urinary bladder cancer	7.6e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—urinary bladder cancer	7.57e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—urinary bladder cancer	7.5e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREBBP—urinary bladder cancer	7.47e-05	0.000159	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—urinary bladder cancer	7.43e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RHOA—urinary bladder cancer	7.41e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—urinary bladder cancer	7.35e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—urinary bladder cancer	7.34e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—urinary bladder cancer	7.32e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—urinary bladder cancer	7.18e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—urinary bladder cancer	7.1e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—urinary bladder cancer	7.08e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—urinary bladder cancer	6.86e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—urinary bladder cancer	6.86e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—urinary bladder cancer	6.82e-05	0.000145	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—urinary bladder cancer	6.78e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RHOA—urinary bladder cancer	6.76e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR3—urinary bladder cancer	6.74e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—urinary bladder cancer	6.74e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—urinary bladder cancer	6.71e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—urinary bladder cancer	6.7e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—urinary bladder cancer	6.69e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—urinary bladder cancer	6.55e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—urinary bladder cancer	6.52e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—urinary bladder cancer	6.5e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—urinary bladder cancer	6.48e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1A—urinary bladder cancer	6.47e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—urinary bladder cancer	6.46e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1A—urinary bladder cancer	6.35e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—urinary bladder cancer	6.34e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—urinary bladder cancer	6.26e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—urinary bladder cancer	6.22e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—urinary bladder cancer	6.16e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR3—urinary bladder cancer	6.15e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—urinary bladder cancer	6.14e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—urinary bladder cancer	6.12e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—urinary bladder cancer	6.05e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—urinary bladder cancer	6.02e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—urinary bladder cancer	5.99e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—urinary bladder cancer	5.97e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—urinary bladder cancer	5.88e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1A—urinary bladder cancer	5.87e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—urinary bladder cancer	5.85e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1A—urinary bladder cancer	5.79e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—urinary bladder cancer	5.78e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREBBP—urinary bladder cancer	5.74e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—urinary bladder cancer	5.67e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—urinary bladder cancer	5.58e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—urinary bladder cancer	5.51e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—urinary bladder cancer	5.43e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—urinary bladder cancer	5.37e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—urinary bladder cancer	5.36e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1A—urinary bladder cancer	5.35e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—urinary bladder cancer	5.34e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—urinary bladder cancer	5.25e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREBBP—urinary bladder cancer	5.23e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RHOA—urinary bladder cancer	5.19e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—urinary bladder cancer	5.17e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—urinary bladder cancer	5.15e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—urinary bladder cancer	5.09e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—urinary bladder cancer	4.96e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—urinary bladder cancer	4.95e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—urinary bladder cancer	4.87e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—urinary bladder cancer	4.86e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—urinary bladder cancer	4.81e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—urinary bladder cancer	4.76e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RHOA—urinary bladder cancer	4.73e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—urinary bladder cancer	4.7e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—urinary bladder cancer	4.56e-05	9.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—urinary bladder cancer	4.49e-05	9.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—urinary bladder cancer	4.44e-05	9.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—urinary bladder cancer	4.44e-05	9.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—urinary bladder cancer	4.41e-05	9.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—urinary bladder cancer	4.38e-05	9.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—urinary bladder cancer	4.36e-05	9.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—urinary bladder cancer	4.34e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—urinary bladder cancer	4.25e-05	9.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—urinary bladder cancer	4.21e-05	8.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—urinary bladder cancer	4.16e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—urinary bladder cancer	4.14e-05	8.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—urinary bladder cancer	4.12e-05	8.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.11e-05	8.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—urinary bladder cancer	4.1e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—urinary bladder cancer	4.1e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—urinary bladder cancer	3.97e-05	8.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—urinary bladder cancer	3.91e-05	8.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—urinary bladder cancer	3.87e-05	8.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—urinary bladder cancer	3.82e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—urinary bladder cancer	3.8e-05	8.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—urinary bladder cancer	3.77e-05	8.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—urinary bladder cancer	3.76e-05	8.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1A—urinary bladder cancer	3.75e-05	7.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—urinary bladder cancer	3.74e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—urinary bladder cancer	3.56e-05	7.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—urinary bladder cancer	3.48e-05	7.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—urinary bladder cancer	3.47e-05	7.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—urinary bladder cancer	3.41e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—urinary bladder cancer	3.33e-05	7.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—urinary bladder cancer	3.15e-05	6.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—urinary bladder cancer	3.11e-05	6.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—urinary bladder cancer	3.04e-05	6.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—urinary bladder cancer	2.87e-05	6.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—urinary bladder cancer	2.8e-05	5.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—urinary bladder cancer	2.68e-05	5.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—urinary bladder cancer	2.55e-05	5.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—urinary bladder cancer	2.44e-05	5.19e-05	CbGpPWpGaD
